ANWFX
Price
$64.67
Change
-$0.78 (-1.19%)
Updated
Feb 21 closing price
Net Assets
147.51B
RNPHX
Price
$64.29
Change
-$0.79 (-1.21%)
Updated
Feb 21 closing price
Net Assets
147.51B
Ad is loading...

ANWFX vs RNPHX

Header iconANWFX vs RNPHX Comparison
Open Charts ANWFX vs RNPHXBanner chart's image
American Funds New Perspective F2
Price$64.67
Change-$0.78 (-1.19%)
VolumeN/A
Net Assets147.51B
American Funds New Perspective R5E
Price$64.29
Change-$0.79 (-1.21%)
VolumeN/A
Net Assets147.51B
ANWFX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ANWFX vs. RNPHX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANWFX is a StrongBuy and RNPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
ANWFX (148B) and RNPHX (148B) have equal amount of cash in the bank . ANWFX (1.03) and RNPHX (1.00) have matching dividends . ANWFX was incepted earlier than RNPHX: ANWFX (17 years) vs RNPHX (9 years). ANWFX (17.00) and RNPHX (17.00) have comparable annual turnover. ANWFX (250) and RNPHX (250) have matching initial minimum investment requirements. ANWFX (10.67) and RNPHX (10.58) have marching annual gain over last year. ANWFX (35.05) and RNPHX (34.72) have equivalent 5 years return.
ANWFXRNPHXANWFX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years9 years-
Gain YTD4.6614.639100%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets148B148B100%
Annual Yield % from dividends1.031.00103%
Returns for 1 year10.6710.58101%
Returns for 3 years15.0114.84101%
Returns for 5 years35.0534.72101%
Returns for 10 years74.13N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO7.960.08
+1.02%
Gogo
PUK17.99-0.18
-0.99%
Prudential PLC
ALLK0.29-0.01
-1.72%
Allakos
RARE42.59-1.89
-4.25%
Ultragenyx Pharmaceutical
SMID34.74-2.37
-6.39%
Smith-Midland Corp